BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 20
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16846)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-9) series.
Item 
Count 
PDF1438
WORD426
HTML12084
Figures (1-2)387
Tables (1-9)262
 Sum=14597
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1175
Download1074
 Sum=2249
May 28, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Tang CM, Yau TO, Yu J. Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments. World J Gastroenterol 2014; 20(20): 6262-6278 [PMID: 24876747 DOI: 10.3748/wjg.v20.i20.6262]
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6262.htm
Number Citing Articles
1
Qiao-Ling Xie, Ying Zhu, Ling-Hong Wu, Lin-Lin Fu, Yan Xiang, Chen-Hua Liu. The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis. PLOS ONE 2015; 10(7): e0132219 doi: 10.1371/journal.pone.0132219
2
Qianying Chen, Hongzhu Chen, Wenjie Wang, Jiali Liu, Wenyue Liu, Ping Ni, Guowei Sang, Guangji Wang, Fang Zhou, Jingwei Zhang. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition. European Journal of Pharmaceutical Sciences 2017; 106: 313 doi: 10.1016/j.ejps.2017.06.015
3
Johan Noble, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing. Renal complications of liver diseases. Expert Review of Gastroenterology & Hepatology 2018; 12(11): 1135 doi: 10.1080/17474124.2018.1530984
4
Tony Mazzulli. Principles and Practice of Pediatric Infectious Diseases. 2023; : 1472 doi: 10.1016/B978-0-323-75608-2.00287-1
5
Ashish Goyal, John M. Murray. Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China. Clinical Drug Investigation 2016; 36(8): 637 doi: 10.1007/s40261-016-0409-8
6
Anastasia Khandazhinskaya, Elena Matyugina, Mikhail Novikov. Coronaviruses and other Novel Antiviral Targets. Annual Reports in Medicinal Chemistry 2021; 57: 175 doi: 10.1016/bs.armc.2021.08.001
7
Maritza Puray-Chavez, Mahmoud Farghali, Vincent Yapo, Andrew Huber, Dandan Liu, Tanyaradzwa Ndongwe, Mary Casey, Thomas Laughlin, Mark Hannink, Philip Tedbury, Stefan Sarafianos. Effects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral Replication. Viruses 2019; 11(7): 651 doi: 10.3390/v11070651
8
Yan Jiao, Wang Lu, Ping Xu, Honglin Shi, Dexi Chen, Yu Chen, Hongbo Shi, Yingmin Ma. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure. Hepatology International 2021; 15(4): 957 doi: 10.1007/s12072-021-10217-3
9
Masatoshi Kakizaki, Yuichiro Yamamoto, Suemi Yabuta, Natsumi Kurosaki, Tatehiro Kagawa, Ai Kotani, Motoyuki Otsuka. The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes. PLOS ONE 2018; 13(12): e0205886 doi: 10.1371/journal.pone.0205886
10
Edward A. Pham, Ryan B. Perumpail, Benjamin J. Fram, Jeffrey S. Glenn, Aijaz Ahmed, Robert G. Gish. Future Therapy for Hepatitis B Virus: Role of Immunomodulators. Current Hepatology Reports 2016; 15(4): 237 doi: 10.1007/s11901-016-0315-9
11
En-Qiang Chen, Shu Feng, Meng-Lan Wang, Ling-Bo Liang, Ling-Yun Zhou, Ling-Yao Du, Li-Bo Yan, Chuan-Min Tao, Hong Tang. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00111-0
12
Grace Bybee, Youra Moeun, Weimin Wang, Kusum K. Kharbanda, Larisa Y. Poluektova, Srivatsan Kidambi, Natalia A. Osna, Murali Ganesan. Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV+ transgenic mice. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1166171
13
Chen Tian, Yuxin Chen, Yong Liu, Shixia Wang, Yang Li, Guiyang Wang, Juan Xia, Xiang-an Zhao, Rui Huang, Shan Lu, Chao Wu. Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans. Emerging Microbes & Infections 2018; 7(1): 1 doi: 10.1038/s41426-018-0034-0
14
Da Cheng, Cichun Wu, Ying Li, Yao Liu, Juan Mo, Lei Fu, Shifang Peng. METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2022; 1865(3): 194782 doi: 10.1016/j.bbagrm.2021.194782
15
Mia Cahill, Chris Ontiveros. The Liver Meeting 2016. EMJ Hepatology 2017; : 2 doi: 10.33590/emjhepatol/10312166
16
Melanie L Yarbrough, Carey-Ann D Burnham. The ABCs of STIs: An Update on Sexually Transmitted Infections. Clinical Chemistry 2016; 62(6): 811 doi: 10.1373/clinchem.2015.240234
17
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
18
Dimitar Gotchev, Bruce D. Dorsey, Duyan Nguyen, Ramesh Kakarla, Benjamin Dugan, Shuai Chen, Min Gao, Laurèn Bailey, Fei Liu, Troy Harasym, Tim Chiu, Sunny Tang, Amy C.-H. Lee, Andrew G. Cole, Michael J. Sofia. Structure–Activity Relationships and Discovery of (S)-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6H-pyrido[1,2-h][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer. Journal of Medicinal Chemistry 2024; 67(2): 1421 doi: 10.1021/acs.jmedchem.3c01981
19
Yingying Mao, Xuejun Wang, Wei Hu, Andrew Li, Ying Li, Hai Huang, Renhe Yan, Yanling Zhang, Jinlong Li, Hongwei Li, Shengqi Wang. Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAs. Antiviral Research 2022; 204: 105366 doi: 10.1016/j.antiviral.2022.105366
20
Jianchun Lu, Lin Lin, Chunyan Ye, Qian Tao, Manman Cui, Shuqin Zheng, Dongmei Zhu, Longgen Liu, Yuan Xue. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure. Annals of Hepatology 2019; 18(1): 155 doi: 10.5604/01.3001.0012.7907
21
Hui Wang, KeHui Liu, Bernard A. M. Fang, HaiQing Wu, FengDi Li, XiaoGang Xiang, WeiLiang Tang, GangDe Zhao, LanYi Lin, Shisan Bao, Qing Xie. Identification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening. Cell & Bioscience 2015; 5(1) doi: 10.1186/s13578-015-0059-1
22
Hans L. Tillmann, Gbeminiyi Samuel. Current state-of-the-art pharmacotherapy for the management of hepatitis B infection. Expert Opinion on Pharmacotherapy 2019; 20(7): 873 doi: 10.1080/14656566.2019.1583744
23
Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee. Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals. Journal of Viral Hepatitis 2023; 30(1): 39 doi: 10.1111/jvh.13765
24
Joel S. Emery, Jordan J. Feld. Treatment of hepatitis B virus with combination therapy now and in the future. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 347 doi: 10.1016/j.bpg.2017.04.007
25
涛 巫. Immunotherapy for Chronic Hepatitis B Virus Infection. Pharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
26
Sihui Zhang, Chao Wang, Bei Liu, Qing-Bin Lu, Jia Shang, Yihua Zhou, Jidong Jia, Xiaoyuan Xu, Huiying Rao, Bingfeng Han, Tianshuo Zhao, Linyi Chen, Mingzhu Xie, Jiahao Cui, Juan Du, Jing zeng, Ninghua huang, Yaqiong Liu, Lei Zhang, Hui Zhuang, Fuqiang Cui. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation. The Lancet Regional Health - Western Pacific 2023; 35: 100738 doi: 10.1016/j.lanwpc.2023.100738
27
Akachukwu Ibezim, Emmanuel Onah, Ebubechukwu N. Dim, Fidele Ntie-Kang. A computational multi-targeting approach for drug repositioning for psoriasis treatment. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03359-2
28
Zhao X. Hu, Yi N. Ye, Wei G. Wu, Xu J. Liang, Qi W. Wu, Ao Zhang, Xing R. Zheng, Zhi L. Gao, Liang Peng, Chan Xie. Real-Life State of Anti-Hepatitis B Virus Drug Choice in Child-Bearing Age Male Patients and Effect on Fertility and Fetal Safety. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/9703907
29
Ramesh P Thylur, Sanjit K Roy, Anju Shrivastava, Thomas A LaVeist, Sharmila Shankar, Rakesh K Srivastava. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma . JGH Open 2020; 4(3): 351 doi: 10.1002/jgh3.12336
30
Knut Stokkeland, Jonas Filip Ludvigsson, Rolf Hultcrantz, Anders Ekbom, Jonas Höijer, Matteo Bottai, Olof Stephansson. Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden. European Journal of Epidemiology 2017; 32(7): 617 doi: 10.1007/s10654-017-0261-z
31
Dengke Teng, Hao Zuo, Lin Liu, Jinghui Dong, Lei Ding. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virology Journal 2018; 15(1) doi: 10.1186/s12985-018-1067-7
32
Seung-Hwa Choi, Keum-Jin Yang, Dong-Soo Lee. Effects of Complementary Combination Therapy of Korean Red Ginseng and Antiviral Agents in Chronic Hepatitis B. The Journal of Alternative and Complementary Medicine 2016; 22(12): 964 doi: 10.1089/acm.2015.0206
33
Ja Yoon Heo, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Young Nyun Park, Sung Soo Ahn, Kwang-Hyub Han, Hyon-Suk Kim. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine 2016; 95(14): e3328 doi: 10.1097/MD.0000000000003328
34
Ceen-Ming Tang. Abnormal liver function tests. InnovAiT: Education and inspiration for general practice 2019; 12(9): 507 doi: 10.1177/1755738019855092
35
Yuichiro Yamamoto, Masatoshi Kakizaki, Takayuki Shimizu, Joaquim Carreras, Tetsuhiro Chiba, Kenji Chamoto, Tatehiro Kagawa, Taku Aoki, Naoya Nakamura, Kiyoshi Ando, Ai Kotani. PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir. International Immunology 2020; 32(8): 519 doi: 10.1093/intimm/dxaa018
36
Mikiko Nakamura, Ayako Suzuki, Junko Akada, Keisuke Tomiyoshi, Hisashi Hoshida, Rinji Akada. End Joining-Mediated Gene Expression in Mammalian Cells Using PCR-Amplified DNA Constructs that Contain Terminator in Front of Promoter. Molecular Biotechnology 2015; 57(11-12): 1018 doi: 10.1007/s12033-015-9890-1
37
Tony Mazzulli. Principles and Practice of Pediatric Infectious Diseases. 2018; : 1434 doi: 10.1016/B978-0-323-40181-4.00287-5
38
Guiying Cao, Jue Liu, Min Liu. Associations of hepatitis B and C in women aged 15–49 years with neonatal preterm birth in 66 high‐income countries, 1990–2019. International Journal of Gynecology & Obstetrics 2024; 164(1): 115 doi: 10.1002/ijgo.14957
39
Vanessa Meier-Stephenson, William T. R. Bremner, Chimone S. Dalton, Guido Van Marle, Carla S. Coffin, Trushar R. Patel. Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations. Viruses 2018; 10(11): 603 doi: 10.3390/v10110603
40
Daniel N Clark, Jianming Hu. Unveiling the Roles of HBV Polymerase for New Antiviral Strategies. Future Virology 2015; 10(3): 283 doi: 10.2217/fvl.14.113
41
Jian Sun, Huiguo Ding, Guofeng Chen, Guiqiang Wang, Lai Wei, Jiming Zhang, Qing Xie, Mobin Wan, Hong Tang, Shijun Chen, Zhiliang Gao, Yuming Wang, Dazhi Zhang, Wenxiang Huang, Jifang Sheng, Qin Ning, Dongliang Yang, Jian Lu, Chen Pan, Yuxiu Yang, Jue Wang, Chuanzhen Sun, Qixin Wang, Jinlin Hou. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0981-5
42
Mai Hashimoto, Kazuaki Taguchi, Takako Ishiguro, Satoru Kohgo, Shuhei Imoto, Keishi Yamasaki, Hiroaki Mitsuya, Masaki Otagiri. Pharmacokinetics studies of 4′-cyano-2′-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats. Journal of Pharmacy and Pharmacology 2018; 70(6): 723 doi: 10.1111/jphp.12897
43
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4): 875 doi: 10.3390/cells9040875
44
Nicholas A. Meanwell. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. Journal of Medicinal Chemistry 2016; 59(16): 7311 doi: 10.1021/acs.jmedchem.6b00915
45
Lesley J. Scott, Henry L. Y. Chan. Tenofovir Alafenamide: A Review in Chronic Hepatitis B. Drugs 2017; 77(9): 1017 doi: 10.1007/s40265-017-0754-9
46
Behnam Azizolahi, Elham Rajaei, Reza Taherkhani, Manoochehr Makvandi. Low detection of hepatitis B and occult hepatitis B infection in patients with rheumatic diseases. The Egyptian Rheumatologist 2017; 39(4): 239 doi: 10.1016/j.ejr.2017.04.009
47
Rongxin Wang, Ruiling Xie, Zongchang Song. Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells. Experimental Cell Research 2018; 365(2): 171 doi: 10.1016/j.yexcr.2018.02.031
48
Zahari Krastev, Diana Petrova, Iskren Kotzev, Mustafa Kemal Celen, Meryl Mendelson, Richa Chandra, Priti Pandey, Kamal Hamed. Telbivudine <i>vs</i> tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study. World Journal of Hepatology 2016; 8(32): 1402-1413 doi: 10.4254/wjh.v8.i32.1402
49
Xiao Li, Tai-Cheng Zhou, Chang-Hui Wu, Li-Lin Tao, Rui Bi, Li-Jun Chen, De-Yao Deng, Chang Liu, Newton O. Otecko, Yang Tang, Xin Lai, Liang Zhang, Jia Wei. Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19184-6
50
Maya A. Singh, Megan M. Chang, Qin Wang, Catherine Rodgers, Barry R. Lutz, Ayokunle O. Olanrewaju. Rapid Enzymatic Assay for Antiretroviral Drug Monitoring Using CRISPR-Cas12a-Enabled Readout. ACS Synthetic Biology 2025;  doi: 10.1021/acssynbio.4c00674
51
F. C. van der Scheun, M. C. M. Nagelkerke, A. Kilaru, V. Shridhar, R. Prasad, T. S. van der Werf. Stigma among healthcare workers towards hepatitis B infection in Bangalore, India: a qualitative study. BMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4606-z
52
Xiu-Mei Chi, Xiao-Mei Wang, Zhong-Feng Wang, Rui-Hong Wu, Xiu-Zhu Gao, Hong-Qin Xu, Yan-Hua Ding, Jun-Qi Niu. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B. World Journal of Gastroenterology 2021; 27(40): 6927-6938 doi: 10.3748/wjg.v27.i40.6927
53
Benjamin W Teh, Monica A Slavin, Simon J Harrison, Leon J Worth. Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization. Expert Review of Anti-infective Therapy 2015; 13(11): 1325 doi: 10.1586/14787210.2015.1083858
54
Jonas Michel Wolf, Vagner Reinaldo Zingalli Bueno Pereira, Patrícia Andréia Zanetti Ballardin Roncato, André Castagna Wortmann, Glaucia Zuleide Stumm, Fernando Oliveira da Silva, Vagner Ricardo Lunge, Daniel Simon. The HLA-G 14-bp insertion/deletion polymorphism is associated with chronic hepatitis B in Southern Brazil: A case-control study. Human Immunology 2020; 81(2-3): 79 doi: 10.1016/j.humimm.2020.01.003
55
Longgen Liu, Jianchun Lu, Chunyan Ye, Lin Lin, Shuqin Zheng, Hongyu Zhang, Qing Lan, Yuan Xue. Serum osteopontin is a predictor of prognosis for HBV‑associated acute‑on‑chronic liver failure. Biomedical Reports 2017;  doi: 10.3892/br.2017.1027
56
X. Wen, H. Su, Y. Wang, Z. Pu, J. Gao, Z. Ji, X. Yuan, X. Li, W. Zhang, L. Zhang, Y. Long, Y. Yan, Z. Shao. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China. Journal of Viral Hepatitis 2018; 25(3): 281 doi: 10.1111/jvh.12805
57
Longgen Liu, Qing Lan, Lin Lin, Jianchun Lu, Chunyan Ye, Qian Tao, Manman Cui, Shuqin Zheng, Xiujun Zhang, Yuan Xue. Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure. Clinica Chimica Acta 2018; 476: 92 doi: 10.1016/j.cca.2017.11.017
58
Florence Defresne, Etienne Sokal. Chronic hepatitis B in children: Therapeutic challenges and perspectives. Journal of Gastroenterology and Hepatology 2017; 32(2): 368 doi: 10.1111/jgh.13459
59
Andrew D. Huber, Dallas L. Pineda, Dandan Liu, Kelsey N. Boschert, Anna T. Gres, Jennifer J. Wolf, Emily M. Coonrod, Jing Tang, Thomas G. Laughlin, Qiongying Yang, Maritza N. Puray-Chavez, Juan Ji, Kamalendra Singh, Karen A. Kirby, Zhengqiang Wang, Stefan G. Sarafianos. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores. ACS Infectious Diseases 2019; 5(5): 750 doi: 10.1021/acsinfecdis.8b00235
60
Eduardo Asín-Prieto, Zinnia P. Parra-Guillen, José David Gómez Mantilla, Joris Vandenbossche, Kim Stuyckens, Xavier Woot de Trixhe, Juan José Perez-Ruixo, Iñaki F. Troconiz. Immune network for viral hepatitis B: Topological representation. European Journal of Pharmaceutical Sciences 2019; 136: 104939 doi: 10.1016/j.ejps.2019.05.017
61
Elaheh Gholami Parizad, Eskandar Gholami Parizad, Afra Khosravi, Mansour Amraei, Azar Valizadeh, Abdoullah Davoudian. Comparing HBV Viral Load in Serum, Cerumen, and Saliva and Correlation With HBeAg Serum Status in Patients With Chronic Hepatitis B Infection. Hepatitis Monthly 2016; 16(5) doi: 10.5812/hepatmon.30385
62
Zhongji Meng, Xiaoyong Zhang, Rongjuan Pei, Ejuan Zhang, Thekla Kemper, Jörg Vollmer, Heather L. Davis, Dieter Glebe, Wolfram Gerlich, Michael Roggendorf, Mengji Lu. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection. Antiviral Research 2016; 125: 14 doi: 10.1016/j.antiviral.2015.11.001
63
Catherine de Martel, Delphine Maucort‐Boulch, Martyn Plummer, Silvia Franceschi. World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 2015; 62(4): 1190 doi: 10.1002/hep.27969
64
Yang Zheng, Jie Wu, Cheng Ding, Kaijin Xu, Shigui Yang, Lanjuan Li. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study. Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-01393-z
65
Giordano Madeddu, Silvia Ortu, Giovanni Garrucciu, Ivana Maida, Michela Melis, Alberto Augusto Muredda, Maria Stella Mura, Sergio Babudieri. DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long‐term nucleo(t)side analogs therapy. Journal of Medical Virology 2017; 89(7): 1208 doi: 10.1002/jmv.24742
66
Eugene Verkhovsky, Paul Naylor, Sindhuri Benjaram, Shanker Das Kundumadam, Murray Ehrinpreis, Milton Mutchnick. Racial disparity in chronic hepatitis B infection in a predominately African American urban clinic population. AIMS Medical Science 2018; 5(4): 378 doi: 10.3934/medsci.2018.4.378
67
Jennifer Wiese, Nayiri A Derian, M'hamed Turki, Tejas Joshi, Ahlim Alsanani, Anjali Satoskar. Rapidly Progressive Glomerulonephritis Associated With IgA Nephropathy and C3 Deposits in a Patient With Chronic Hepatitis B. Cureus 2024;  doi: 10.7759/cureus.70619
68
Shelina Moonsamy, Pavitra Pillay, Nishi Prabdial-Sing, Abram L. Wagner. Hepatitis B infection status among South Africans attending public health facilities over a five-year period: 2015 to 2019. PLOS Global Public Health 2023; 3(9): e0000992 doi: 10.1371/journal.pgph.0000992
69
Alyssa A. Kunkel, Kevin J. McHugh. Injectable controlled‐release systems for the prevention and treatment of infectious diseases. Journal of Biomedical Materials Research Part A 2024; 112(8): 1224 doi: 10.1002/jbm.a.37615
70
Gao-yun Chen, Min Liu, Meng-bin Yu, Chao Zheng, Si-chen Wei, I. Demetrescu, K. Oh, N.K. Kaushik, A. Butu, F. Othman. Study on the Chemical Constituents and anti-HBV Activity ofHypericum japonica. MATEC Web of Conferences 2016; 60: 03002 doi: 10.1051/matecconf/20166003002
71
Wen-Pei Wu, Cheng-In Hoi, Ran-Chou Chen, Ching-Po Lin, Chen-Te Chou. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis. Medicine 2017; 96(42): e8339 doi: 10.1097/MD.0000000000008339
72
Tung-Hung Su, Jia-Horng Kao. Improving clinical outcomes of chronic hepatitis B virus infection. Expert Review of Gastroenterology & Hepatology 2015; 9(2): 141 doi: 10.1586/17474124.2015.960398
73
Yin Zhang, Yanming Xie, Yiying Zhang, Yan Liu, Yan Zhuang. Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tablets. Biomedical Reports 2016; 5(5): 595 doi: 10.3892/br.2016.765
74
Huanhuan Wei, Zehua Shao, Fangfang Fu, Xuan Yu, Yaping Wu, Yan Bai, Wei Wei, Nan Meng, Kewei Liu, Hui Han, Meiyun Wang. Value of multimodal MRI radiomics and machine learning in predicting staging liver fibrosis and grading inflammatory activity. The British Journal of Radiology 2023; 96(1141) doi: 10.1259/bjr.20220512
75
Yiyu Lu, Zhaoyuan Fang, Tao Zeng, Meiyi Li, Qilong Chen, Hui Zhang, Qianmei Zhou, Yiyang Hu, Luonan Chen, Shibing Su. Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers. Chinese Medicine 2019; 14(1) doi: 10.1186/s13020-019-0275-4
76
Jun-Feng Li, Xiao-Peng Dai, Wei Zhang, Shi-Hui Sun, Yang Zeng, Guang-Yu Zhao, Zhi-Hua Kou, Yan Guo, Hong Yu, Lan-Ying Du, Shi-Bo Jiang, Yu-Sen Zhou, John M. Taylor, Michael J. Imperiale. Upregulation of MicroRNA-146a by Hepatitis B Virus X Protein Contributes to Hepatitis Development by Downregulating Complement Factor H. mBio 2015; 6(2) doi: 10.1128/mBio.02459-14
77
Michelle Pardee. Diagnosis and Management of Hepatitis B and C. Nursing Clinics of North America 2019; 54(2): 277 doi: 10.1016/j.cnur.2019.02.004
78
Shu-Rong Xiao, Gui-Dan Xu, Wu-Jun Wei, Bin Peng, Yi-Bin Deng. Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice. World Journal of Clinical Cases 2018; 6(8): 183-191 doi: 10.12998/wjcc.v6.i8.183
79
Justin B. Safari, Alain M. Bapolisi, Rui W. M. Krause. Development of pH-Sensitive Chitosan-g-poly(acrylamide-co-acrylic acid) Hydrogel for Controlled Drug Delivery of Tenofovir Disoproxil Fumarate. Polymers 2021; 13(20): 3571 doi: 10.3390/polym13203571
80
Tianyou Ma, Xiaohui Wei, Xiaoming Wu, Jianqiang Du. Trends and future projections of liver cancer incidence in Hong Kong: a population-based study. Archives of Public Health 2023; 81(1) doi: 10.1186/s13690-023-01191-3
81
M. A. A. van de Klundert, H. L. Zaaijer, N. A. Kootstra. Identification of FDA‐approved drugs that target hepatitis B virus transcription. Journal of Viral Hepatitis 2016; 23(3): 191 doi: 10.1111/jvh.12479
82
Shahnaz Sali, Maryam Nasiri. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad Hospital. Jundishapur Journal of Natural Pharmaceutical Products 2019; 14(3) doi: 10.5812/jjnpp.63023
83
Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology 2017; 5(4): 297 doi: 10.14218/JCTH.2016.00019
84
Lu Xu, Tian Xie, Tao Shen, Shengnan Jian. Yinchenhao decoction for chronic hepatitis B. Medicine 2019; 98(8): e14648 doi: 10.1097/MD.0000000000014648
85
Soheil Tavakolpour, Hajar Sadat Mirsafaei, Somayeh Elkaei Behjati, Mojtaba Ghasemiadl, Meisam Akhlaghdoust, Shahnaz Sali. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy. Immunology Letters 2017; 190: 206 doi: 10.1016/j.imlet.2017.08.003
86
Aswin Damodaran, Subin Mary Zachariah, Sreeja Chandrasekharan Nair. Novel Therapeutic Approaches for the Management of Hepatitis Infections. Therapeutic Delivery 2024; 15(3): 211 doi: 10.4155/tde-2023-0074
87
Sobia Manzoor, Muhammad Saalim, Muhammad Imran, Saleha Resham, Javed Ashraf. Hepatitis B virus therapy: What&rsquo;s the future holding for us?. World Journal of Gastroenterology 2015; 21(44): 12558-12575 doi: 10.3748/wjg.v21.i44.12558
88
P. H. Naylor, M. G. Mutchnick. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. Journal of Viral Hepatitis 2018; 25(1): 4 doi: 10.1111/jvh.12807
89
Getu Zhaori. Potential clinical application of RNAi‐based therapeutic strategies for treatment of chronic hepatitis B. Pediatric Investigation 2018; 2(1): 4 doi: 10.1002/ped4.12018
90
Song Yang, Huichun Xing, Yuming Wang, Jinlin Hou, Duande Luo, Qing Xie, Qin Ning, Hong Ren, Huiguo Ding, Jifang Sheng, Lai Wei, Shijun Chen, Xiaoling Fan, Wenxiang Huang, Chen Pan, Zhiliang Gao, Jiming Zhang, Boping Zhou, Guofeng Chen, Mobin Wan, Hong Tang, Guiqiang Wang, Yuxiu Yang, Dongping Xu, Peiling Dong, Qixin Wang, Jue Wang, Fernando A. Bognar, Daozhen Xu, Jun Cheng. HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0640-1
91
Fangfang Fu, Xiaodong Li, Qiuyu Liu, Cuiyun Chen, Yan Bai, Dapeng Shi, Jia Sang, Kaiyu Wang, Meiyun Wang. Noninvasive DW-MRI metrics for staging hepatic fibrosis and grading inflammatory activity in patients with chronic hepatitis B. Abdominal Radiology 2021; 46(5): 1864 doi: 10.1007/s00261-020-02801-2
92
Geanne da Silva Lobato, Ademilton Alves Farias, Alessandra Pereira da Silva, José Raul Rocha de Araújo Júnior. Drug treatment of chronic hepatitis b in Brazil: a review. Gastroenterology & Hepatology: Open Access 2021; 12(6): 182 doi: 10.15406/ghoa.2021.12.00483
93
Qi-wen Chen, Hai-jin Li, Ya-nan Chen, Zhou-yu Ning, Song Gao, Ye-hua Shen, Zhi-qiang Meng, Sonya Vargulick, Bi-yun Wang, Hao Chen, Do Young Kim. Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma. PLOS ONE 2016; 11(1): e0139782 doi: 10.1371/journal.pone.0139782
94
Elaine Tang, Sharon Torres, Benny Liu, Rachel Baden, Taft Bhuket, Robert J. Wong. High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection. Journal of Clinical and Experimental Hepatology 2018; 8(3): 235 doi: 10.1016/j.jceh.2017.11.009
95
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, Mathias Haag, Ute Hofmann, Matthias Schwab, Stephan Urban, Gerd Mikus, David Czock, Walter E. Haefeli, Antje Blank. Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1128547
96
Carla S. Coffin, Samuel S. Lee. New paradigms in hepatitis B management: only diamonds are forever. British Medical Bulletin 2015; : ldv039 doi: 10.1093/bmb/ldv039
97
Pu Zhou, Feifei Yang, Jinyu Wang, Richeng Mao, Xun Qi, Yuxian Huang, Jiming Zhang. Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients. Medicine 2015; 94(17): e730 doi: 10.1097/MD.0000000000000730
98
Andrew D. Huber, Eleftherios Michailidis, Jing Tang, Maritza N. Puray-Chavez, Maria Boftsi, Jennifer J. Wolf, Kelsey N. Boschert, Megan A. Sheridan, Maxwell D. Leslie, Karen A. Kirby, Kamalendra Singh, Hiroaki Mitsuya, Michael A. Parniak, Zhengqiang Wang, Stefan G. Sarafianos. 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H. Antimicrobial Agents and Chemotherapy 2017; 61(6) doi: 10.1128/AAC.00245-17
99
Wen-xiong Xu, Qian Zhang, Xiang Zhu, Chao-shuang Lin, You-ming Chen, Hong Deng, Yong-yu Mei, Zhi-xin Zhao, Dong-ying Xie, Zhi-liang Gao, Chan Xie, Liang Peng. 48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/1817680
100
Tai-Ping Li, Shi-He Guan, Qin Wang, Li-Wen Chen, Kai Yang, Hao Zhang. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure. World Journal of Gastroenterology 2019; 25(37): 5667-5675 doi: 10.3748/wjg.v25.i37.5667
101
Chunlin Li, Yu Yang, Yingjian Wang, Shurong Dong, Ya Yang, Ying Shi, Linhan Li, Feng Jiang, Yue Chen, Qingwu Jiang, Yibiao Zhou. Impact of maternal HIV–HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest China. Sexually Transmitted Infections 2020; 96(7): 509 doi: 10.1136/sextrans-2019-054295
102
Ji Yun Lee, Sung Hee Lim, Min‐Young Lee, Haesu Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Chul Won Jung, Jun Ho Jang, Won Seog Kim, Seok Jin Kim, Kihyun Kim. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver International 2015; 35(11): 2363 doi: 10.1111/liv.12838
103
Chun-Ta Lin, Yue-Ting Hsieh, Yeng-Jey Yang, Shih-Hui Chen, Cheng-Hsuan Wu, Lih-Hwa Hwang. B-Cell Lymphoma 6 (BCL6) Is a Host Restriction Factor That Can Suppress HBV Gene Expression and Modulate Immune Responses. Frontiers in Microbiology 2019; 9 doi: 10.3389/fmicb.2018.03253
104
Wei Wu, Yu Zhu, Chenbo Yu, Shigui Yang, Bing Ruan, Yu Chen, Lanjuan Li. Clinical features of treatment-naive patients with hepatitis B virus infection. Medicine 2017; 96(16): e6660 doi: 10.1097/MD.0000000000006660
105
Xiaoyu Fu, Yi Ouyang, Juan Mo, Ronghua Li, Lei Fu, Shifang Peng. Upregulation of microRNA-328-3p by hepatitis B virus contributes to THLE-2 cell injury by downregulating FOXO4. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02299-8
106
Rahila Zannat Sadiea, Shahnaj Sultana, Bijan Mohon Chaki, Tasnim Islam, Sharmy Dash, Sharmin Akter, Md Sayeedul Islam, Taheruzzaman Kazi, Abir Nagata, Rocco Spagnuolo, Rosellina Margherita Mancina, Md Golzar Hossain. Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches. International Journal of Molecular Sciences 2022; 23(3): 1617 doi: 10.3390/ijms23031617
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345